Loading clinical trials...
Loading clinical trials...
A Randomized Multicenter Phase II/III Study of Optimized Treatment Strategies for Stage II and III Nasopharyngeal Carcinoma
Conditions
Interventions
Docetaxel
Cisplatin
+1 more
Locations
1
China
Chinese Academy of Medical Sciences
Beijin, China
Start Date
June 15, 2019
Primary Completion Date
May 1, 2021
Completion Date
May 1, 2025
Last Updated
January 29, 2021
NCT06636734
NCT05063552
Lead Sponsor
Chinese Academy of Medical Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions